Contracting Out Gives Laboratories An In With Diagnostics Manufacturers
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers and laboratories have until September to begin complying with FDA's analyte specific reagent policy, clarified in 2007 guidelines. But some labs, particularly those specializing in molecular diagnostics, are scrambling to fill what could be a gap in needed supplies
You may also be interested in...
Test Makers Have One Year To Comply With New ASR Guidelines
Diagnostic test makers will have until September 2008 to comply with newly clarified FDA policies for analyte specific reagents
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.